Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Viremia D014766 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Imagawa M et al. Modulation of platelet-activating factor synthesis by recombinant interferon-alpha in human renal cell carcinoma. 1996 Urol. Int. pmid:8840484
Mehta A and Sigman M Identification and preparation of sperm for ART. 2014 Urol. Clin. North Am. pmid:24286775
Yildirim G et al. Effects of platelet-activating factor and hyperbaric oxygenation on antioxidant defense and duodenal contractility. 2000 Undersea Hyperb Med pmid:11191161
Vavilova GL et al. [The role of the thrombocyte-activating factor in inhibiting Na+,K(+)-ATPase in different tissues after ischemia and reperfusion of the small intestine]. 1996 Mar-Apr Ukr. Biokhim. Zh. pmid:9005660
Hansen JF and Hansen BF [Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology]. 1987 Ugeskr. Laeg. pmid:3324429
Kabasakal C et al. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis. 1998 Jul-Sep Turk. J. Pediatr. pmid:9763906
Harputluoglu MM et al. The effects of Gingko biloba extract on acetic acid-induced colitis in rats. 2006 Turk J Gastroenterol pmid:16941250
GamaleÄ­ IA et al. [Post-receptor formation of active forms of oxygen in nonphagocytic cells]. 1999 Tsitologiia pmid:10496012
Braquet P et al. Is there a case for PAF antagonists in the treatment of ischemic states? 1989 Trends Pharmacol. Sci. pmid:2688213
Izzo AA et al. Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. 1998 Trends Pharmacol. Sci. pmid:9803830
Page C and Abbott A PAF: new antagonists, new roles in disease and a major role in reproductive biology. 1989 Trends Pharmacol. Sci. pmid:2672467
García-Sáinz JA Intercellular communication within the liver has clinical implications. 1989 Trends Pharmacol. Sci. pmid:2595791
O'Neill C A physiological role for PAF in the stimulation of mammalian embryonic development. 1991 Trends Pharmacol. Sci. pmid:2053190
Zimmerman GA and McIntyre TM PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. 2004 Trends Mol Med pmid:15177186
Marathe GK et al. Oxidized LDL contains inflammatory PAF-like phospholipids. 2001 Apr-May Trends Cardiovasc. Med. pmid:11686003
Foegh ML et al. Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet-activating factor. 1986 Transplantation pmid:3523888
Asako H et al. Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules. 1992 Transplantation pmid:1384191
Gu M et al. Pharmacologic graft protection without donor pretreatment in liver transplantation from non-heart-beating donors. 2000 Transplantation pmid:11045637
Camussi G et al. Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. 1987 Transplantation pmid:3299910
Suzuki S et al. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. 2000 Transplantation pmid:10868624